Results from the Canadian Nosocomial infection surveillance program on Carbapenemase-producing Enterobacteriaceae, 2010 to 2014

Antimicrobial Agents and Chemotherapy

Volumn 60, Issue 11, 2016, Pages 6787-6794

  Mataseje, Laura F ^a   Abdesselam, Kahina ^a   Vachon, Julie ^a   Mitchel, Robyn ^a   Bryce, Elizabeth ^c   Roscoe, Diane ^b   Boyd, David A ^a   Embree, Joanne ^a   Katz, Kevin ^d   Kibsey, Pamela ^e   Simor, Andrew E ^f   Taylor, Geoffrey ^g   Turgeon, Nathalie ^h   Langley, Joanne ⁱ   Gravel, Denise ^a   Amaratunga, Kanchana ^a   Mulvey, Michael R ^a  

^a PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^b VANCOUVER GENERAL HOSPITAL   (Canada)

^c UNIVERSITY OF MANITOBA   (Canada)

^d NORTH YORK GENERAL HOSPITAL   (Canada)

^e VICTORIA GENERAL HOSPITAL   (Canada)

^f SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^g UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

^h LAVAL UNIVERSITY   (Canada)

ⁱ IWK HEALTH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEMASE; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BETA LACTAMASE; CARBAPENEM DERIVATIVE;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL TRANSMISSION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CANADA; CARBAPENEM RESISTANT ENTEROBACTERIACEAE; CARBAPENEMASE PRODUCING ENTEROBACTERIACEAE; CHILD; FEMALE; HOSPITAL INFECTION; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; MORTALITY RATE; MULTILOCUS SEQUENCE TYPING; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TRAVEL; ANTIBIOTIC RESISTANCE; CHEMISTRY; CLASSIFICATION; CLINICAL TRIAL; CROSS INFECTION; DRUG EFFECTS; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; GENE EXPRESSION; GENETICS; HEALTH SURVEY; HOSPITAL; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PLASMID; PRESCHOOL CHILD; PREVALENCE; STATISTICS AND NUMERICAL DATA; SURVIVAL ANALYSIS;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CANADA; CARBAPENEMS; CHILD; CHILD, PRESCHOOL; CROSS INFECTION; ELECTROPHORESIS, GEL, PULSED-FIELD; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; FEMALE; GENE EXPRESSION; HOSPITALS; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; MULTILOCUS SEQUENCE TYPING; PLASMIDS; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PREVALENCE; PUBLIC HEALTH SURVEILLANCE; SURVIVAL ANALYSIS; TRAVEL;

EID: 84994890351     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01359-16     Document Type: Article

References (39)

1. Zhanel GG, Adam HJ, Baxter MR, Fuller J, Nichol KA, Denisuik AJ, Lagace-Wiens PR, Walkty A, Karlowsky JA, Schweizer F, Hoban DJ, Canadian Antimicrobial Resistance Alliance. 2013. Antimicrobial susceptibility of 22746 pathogens from Canadian hospitals: results of the CANWARD 2007-11 study. J Antimicrob Chemother 68(Suppl 1):i7-i22.
2. Queenan AM, Bush K. 2007. Carbapenemases: The versatile betalactamases. Clin Microbiol Rev 20:440-458. http://dx.doi.org/10.1128/CMR.00001-07.
3. Falagas ME, Karageorgopoulos DE, Nordmann P. 2011. Therapeutic options for infections with Enterobacteriaceae producing carbapenemhydrolyzing enzymes. Future Microbiol 6:653-666. http://dx.doi.org/10.2217/fmb.11.49.
4. Mataseje LF, Bryce E, Roscoe D, Boyd DA, Embree J, Gravel D, Katz K, Kibsey P, Kuhn M, Mounchili A, Simor A, Taylor G, Thomas E, Turgeon N, Mulvey MR, Canadian Nosocomial Infection Surveillance Program. 2012. Carbapenem-resistant Gram-negative bacilli in Canada 2009-10: results from the Canadian Nosocomial Infection Surveillance Program (CNISP). J Antimicrob Chemother 67:1359-1367. http://dx.doi.org/10.1093/jac/dks046.
5. Williams V, Simor AE, Kiss A, McGeer A, Hirji Z, Larios OE, Moore C, Weiss K, Infection Prevention and Control-Canada. 2015. Is the prevalence of antibiotic-resistant organisms changing in Canadian hospitals? Comparison of point-prevalence survey results in 2010 and 2012. Clin Microbiol Infect 21:553-559.
6. Goldfarb D, Harvey SB, Jessamine K, Jessamine P, Toye B, Desjardins M. 2009. Detection of plasmid-mediated KPC-producing Klebsiella pneumoniae in Ottawa, Canada: evidence of intrahospital transmission. J Clin Microbiol 47:1920-1922. http://dx.doi.org/10.1128/JCM.00098-09.
7. Mataseje LF, Boyd DA, Willey BM, Prayitno N, Kreiswirth N, Gelosia A, Poutanen SM, Low DE, Jenkins SG, Katz K, Mulvey MR. 2011. Plasmid comparison and molecular analysis of Klebsiella pneumoniae harbouring bla(KPC) from New York City and Toronto. J Antimicrob Chemother 66:1273-1277. http://dx.doi.org/10.1093/jac/dkr092.
8. Leung V, Loo VG, Frenette C, Domingo MC, Bourgault AM, Mulvey MR, Robson HG. 2012. First Canadian outbreak of Enterobacteriaceaeexpressing Klebsiella pneumoniae carbapenemase type 3. Can J Infect Dis Med Microbiol 23:117-120.
9. Ahmed-Bentley J, Chandran AU, Joffe AM, French D, Peirano G, Pitout JD. 2013. Gram-negative bacteria that produce carbapenemases causing death attributed to recent foreign hospitalization. Antimicrob Agents Chemother 57:3085-3091. http://dx.doi.org/10.1128/AAC.00297-13.
10. Mulvey MR, Grant JM, Plewes K, Roscoe D, Boyd DA. 2011. New Delhi metallo-beta-lactamase in Klebsiella pneumoniae and Escherichia coli, Canada. Emerg Infect Dis 17:103-106. http://dx.doi.org/10.3201/eid1701.101358.
11. Ellis C, Chung C, Tijet N, Patel SN, Desjardins M, Melano RG, Toye B. 2013. OXA-48-like carbapenemase-producing Enterobacteriaceae in Ottawa, Canada. Diagn Microbiol Infect Dis 76:399-400. http://dx.doi.org/10.1016/j.diagmicrobio.2013.04.017.
12. Mataseje LF, Boyd DA, Hoang L, Imperial M, Lefebvre B, Miller M, Poutanen SM, Roscoe D, Willey BM, Mulvey MR. 2013. Carbapenemhydrolyzing oxacillinase-48 and oxacillinase-181 in Canada, 2011. Emerg Infect Dis 19:157-160. http://dx.doi.org/10.3201/eid1901.120706.
13. Lowe CF, Kus JV, Salt N, Callery S, Louie L, Khan MA, Vearncombe M, Simor AE. 2013. Nosocomial transmission of New Delhi metallobeta-lactamase-1-producing Klebsiella pneumoniae in Toronto, Canada. Infect Control Hosp Epidemiol 34:49-55. http://dx.doi.org/10.1086/668778.
14. Haraoui LP, Levesque S, Lefebvre B, Blanchette R, Tomkinson M, Mataseje L, Mulvey MR, Miller MA. 2013. Polyclonal outbreak of KPC-3-producing Enterobacter cloacae at a single hospital in Montreal, Quebec, Canada. J Clin Microbiol 51:2406-2408.
15. Clinical and Laboratory Standards Institute. 2016. Performance standards for antimicrobial susceptibility testing, 26th ed. CLSI supplement M100S. Clinical and Laboratory Standards Institute, Wayne, PA.
16. Poirel L, Heritier C, Tolun V, Nordmann P. 2004. Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae. Antimicrob Agents Chemother 48:15-22. http://dx.doi.org/10.1128/AAC.48.1.15-22.2004.
17. Naas T, Cuzon G, Villegas MV, Lartigue MF, Quinn JP, Nordmann P. 2008. Genetic structures at the origin of acquisition of the beta-lactamase bla KPC gene. Antimicrob Agents Chemother 52:1257-1263. http://dx.doi.org/10.1128/AAC.01451-07.
18. Carattoli A, Bertini A, Villa L, Falbo V, Hopkins KL, Threlfall EJ. 2005. Identification of plasmids by PCR-based replicon typing. J Microbiol Methods 63:219-228. http://dx.doi.org/10.1016/j.mimet.2005.03.018.
19. García-Fernández A, Fortini D, Veldman K, Mevius D, Carattoli A. 2009. Characterization of plasmids harbouring qnrS1, qnrB2 and qnrB19 genes in Salmonella. J Antimicrob Chemother 63:274-281.
20. Clinical and Laboratory Standards Institute. 2014. Performance standards for antimicrobial susceptibility testing; twenty-fourth informational supplement. CLSI document M100-24. Clinical and Laboratory Standards Institute, Wayne, PA.
21. German GJ, Jamieson FB, Gilmour M, Almohri H, Bullard J, Domingo MC, Fuller J, Girouard G, Haldane D, Hoang L, Levett PN, Longtin J, Melano R, Needle R, Patel SN, Rebbapragada A, Reyes RC, Mulvey MR. 2016. Interim recommendations of the reporting of extensively drug resistant and pan-drug resistant isolates of Enterobacteriaceae, Pseudomonas aeruginosa, Acinetobacter spp. and Stenotrophomonas maltophilia. Can Commun Dis Rep 42:91-97.
22. Mataseje LF, Boyd DA, Delport J, Hoang L, Imperial M, Lefebvre B, Kuhn M, Van Caeseele P, Willey BM, Mulvey MR. 2014. Serratia marcescens harbouring SME-Type class A carbapenemases in Canada and the presence of blaSME on a novel genomic island, SmarGI1-1. J Antimicrob Chemother 69:1825-1829.
23. Nordmann P, Poirel L. 2014. The difficult-To-control spread of carbapenemase producers among Enterobacteriaceae worldwide. Clin Microbiol Infect 20:821-830. http://dx.doi.org/10.1111/1469-0691.12719.
24. Yong D, Toleman MA, Giske CG, Cho HS, Sundman K, Lee K, Walsh TR. 2009. Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother 53:5046-5054. http://dx.doi.org/10.1128/AAC.00774-09.
25. Carrër A, Poirel L, Yilmaz M, Akan OA, Feriha C, Cuzon G, Matar G, Honderlick P, Nordmann P. 2010. Spread of OXA-48-encoding plasmid in Turkey and beyond. Antimicrob Agents Chemother 54:1369-1373. http://dx.doi.org/10.1128/AAC.01312-09.
26. Castanheira M, Deshpande LM, Mathai D, Bell JM, Jones RN, Mendes RE. 2011. Early dissemination of NDM-1-And OXA-181-producing Enterobacteriaceae in Indian hospitals: report from the SENTRY Antimicrobial Surveillance Program, 2006-2007. Antimicrob Agents Chemother 55:1274-1278. http://dx.doi.org/10.1128/AAC.01497-10.
27. Poirel L, Potron A, Nordmann P. 2012. OXA-48-like carbapenemases: The phantom menace. J Antimicrob Chemother 67:1597-1606. http://dx.doi.org/10.1093/jac/dks121.
28. Nordmann P, Dortet L, Poirel L. 2012. Carbapenem resistance in Enterobacteriaceae: here is the storm! Trends Mol Med 18:263-272.
29. Tzouvelekis LS, Markogiannakis A, Piperaki E, Souli M, Daikos GL. 2014. Treating infections caused by carbapenemase-producing Enterobacteriaceae. Clin Microbiol Infect 20:862-872. http://dx.doi.org/10.1111/1469-0691.12697.
30. Ö sterblad M, Kirveskari J, Hakanen AJ, Tissari P, Vaara M, Jalava J. 2012. Carbapenemase-producing Enterobacteriaceae in Finland: The first years (2008-11). J Antimicrob Chemother 67:2860-2864. http://dx.doi.org/10.1093/jac/dks299.
31. Giske CG, Froding I, Hasan CM, Turlej-Rogacka A, Toleman M, Livermore D, Woodford N, Walsh TR. 2012. Diverse sequence types of Klebsiella pneumoniae contribute to the dissemination of blaNDM-1 in India, Sweden, and the United Kingdom. Antimicrob Agents Chemother 56:2735-2738. http://dx.doi.org/10.1128/AAC.06142-11.
32. Tzouvelekis LS, Markogiannakis A, Psichogiou M, Tassios PT, Daikos GL. 2012. Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: An evolving crisis of global dimensions. Clin Microbiol Rev 25:682-707. http://dx.doi.org/10.1128/CMR.05035-11.
33. Damjanova I, Toth A, Paszti J, Hajbel-Vekony G, Jakab M, Berta J, Milch H, Fuzi M. 2008. Expansion and countrywide dissemination of ST11, ST15 and ST147 ciprofloxacin-resistant CTX-M-15-Type betalactamase-producing Klebsiella pneumoniae epidemic clones in Hungary in 2005-The new 'MRSAs'? J Antimicrob Chemother 62:978-985. http://dx.doi.org/10.1093/jac/dkn287.
34. Giakkoupi P, Papagiannitsis CC, Miriagou V, Pappa O, Polemis M, Tryfinopoulou K, Tzouvelekis LS, Vatopoulos AC. 2011. An update of the evolving epidemic of blaKPC-2-carrying Klebsiella pneumoniae in Greece (2009-10). J Antimicrob Chemother 66:1510-1513. http://dx.doi.org/10.1093/jac/dkr166.
35. Richter SN, Frasson I, Franchin E, Bergo C, Lavezzo E, Barzon L, Cavallaro A, Palu G. 2012. KPC-mediated resistance in Klebsiella pneumoniae in two hospitals in Padua, Italy, June 2009-December 2011: massive spreading of a KPC-3-encoding plasmid and involvement of nonintensive care units. Gut Pathog 4:7-15. http://dx.doi.org/10.1186/1757-4749-4-7.
36. Baraniak A, Grabowska A, Izdebski R, Fiett J, Herda M, Bojarska K, Zabicka D, Kania-Pudlo M, Mlynarczyk G, Zak-Pulawska Z, Hryniewicz W, Gniadkowski M, KPC-PL Study Group. 2011. Molecular characteristics of KPC-producing Enterobacteriaceae at the early stage of their dissemination in Poland, 2008-2009. Antimicrob Agents Chemother 55: 5493-5499. http://dx.doi.org/10.1128/AAC.05118-11.
37. García-Fernández A, Villa L, Carta C, Venditti C, Giordano A, Venditti M, Mancini C, Carattoli A. 2012. Klebsiella pneumoniae ST258 producing KPC-3 identified in Italy carries novel plasmids and OmpK36/OmpK35 porin variants. Antimicrob Agents Chemother 56:2143-2145. http://dx.doi.org/10.1128/AAC.05308-11.
38. Leavitt A, Carmeli Y, Chmelnitsky I, Goren MG, Ofek I, Navon-Venezia S. 2010. Molecular epidemiology, sequence types, and plasmid analyses of KPC-producing Klebsiella pneumoniae strains in Israel. Antimicrob Agents Chemother 54:3002-3006. http://dx.doi.org/10.1128/AAC.01818-09.
39. Leavitt A, Chmelnitsky I, Ofek I, Carmeli Y, Navon-Venezia S. 2010. Plasmid pKpQIL encoding KPC-3 and TEM-1 confers carbapenem resistance in an extremely drug-resistant epidemic Klebsiella pneumoniae strain. J Antimicrob Chemother 65:243-248. http://dx.doi.org/10.1093/jac/dkp417.